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Tumors of the olfactory groove may cause unilateral optic atrophy with contralateral
papilledema and anosmia (Foster Kennedy syndrome). We describe a case of a young
pregnant woman with Foster Kennedy syndrome due to an olfactory groove meningioma.
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CASE PRESENTATION
A 37-year-old right handed woman from Rwanda in her 37th preg-
nancy week presented to our Emergency Department in labor.
She was admitted to the High Risk Maternal Fetal Medicine
Service. Neurology was consulted for assessment of protracted
headaches of approximately 2 years duration, worsening since the
first trimester of her pregnancy. In addition, visual acuity of her
left eye (OS) had gradually worsened during the same period of
time, resulting in complete monocular visual loss.
She had no history of nausea, vomiting, transient visual obscu-
rations, galactorrhea, rhinorrhea, or seizures. She had no exposure
to ionizing radiation or repeated cranial trauma.
On neurologic examination she had bilateral anosmia, lack
of light perception OS, and visual acuity was 20/20 OD. There
was a left relative afferent pupillary defect (APD). Funduscopy
showed pallor of the left optic disk and blurred nasal margins
of the right optic disk. Complete blood count (CBC), complete
metabolic profile (CMP), thyroid stimulating hormone (TSH),
prolactin, follicular stimulating hormone, luteinizing hormone
(LH), and growth hormone (GH) were within the normal range
expected during pregnancy. MRI of the brain without contrast
showed a 3.7 cm× 3.2 cm× 1.4 cm homogeneously isointense on
T1 suprasellar mass along the dural floor of the cranial fossa with
compression of the left optic apex with moderate edema and no
hydrocephalus. This was a significant increase from her previous
MRI done a year earlier in Rwanda (Figure 1). After the first MRI
she was told to come to the US to seek neurosurgical intervention.
At our institution, she received dexamethasone 4 mg every 6 h
and had an uneventful delivery through a cesarean section (C-
Section). Three days after C-section, a bicoronal craniotomy was
done with subtotal tumor removal. A temporary lumbar drain
was placed. Levetiracetam for seizure prophylaxis was given and
dexamethasone taper was started on postoperative day 5. Surgical
pathology showed meningioma WHO grade I, positive for prog-
esterone receptors. The Ki-67 proliferation index overall was less
than 1% (Figures 2 and 3). Following surgery, she was able to
perceive light and motion with her OS.
DISCUSSION
The clinical presentation of unilateral optic atrophy with con-
tralateral papilledema and anosmia was first fully described by
Kennedy in 1911 (1). Mass lesions accounting for Foster Kennedy
syndrome are frequently located in the olfactory groove, falx
cerebri, sphenoid wing, or subfrontal region (2). Most masses
are neoplastic, and meningiomas are the most prevalent lesions.
Other reported mass lesions causing Foster Kennedy syndrome
include frontal lobe abscesses, craniopharyngiomas, pituitary ade-
nomas, plasmacytomas, nasopharyngeal angiofibromas, neurob-
lastomas, and aneurysms (2). Direct compression of one optic
nerve accounts for ipsilateral optic atrophy. Raised intracranial
pressure (ICP) causes contralateral papilledema that usually pre-
cedes the ipsilateral optic atrophy (3) However, bilateral optic
nerve compression without elevation of ICP, and chronic ele-
vated ICP with compression have been postulated as other pos-
sible mechanisms (4). Headaches, emotional lability, memory
loss, nausea, vomiting, or weakness may also be present (4).
Visual changes may present as transient visual obscurations, cen-
tral scotomata, unilateral or bilateral visual loss, or visual field
defects (4).
Meningiomas account for 15% of all intracranial tumors, and
may present as a solitary mass or as multiple masses, the latter
usually associated with neurofibromatosis type 2. Most common
locations of meningiomas are over the convexities of the parasagit-
tal sphenoid ridge, olfactory groove, suprasellar/parasellar regions,
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FIGURE 1 | MRI of the brain with and without contrast done in
Rwanda 1 year previous to admission to our institution showed
3 cm×2.6 cm×1.2 cm homogeneously enhancing suprasellar mass
along the dural floor of the cranial fossa.
FIGURE 2 |The specimen consists of uniform, benign-appearing,
spindle-shaped cells with whorl formations containing hyalinized
material with some degeneration. In time, with calcification, these whorls
will progress to psammoma bodies classically observed in meningiomas.
tentorium cerebelli, pineal region, optic nerve, and foramen
magnum (5).
Olfactory groove meningiomas (OGM) account for 8–13% of
all intracranial meningiomas (5). These tumors arise in the mid-
line of the cribriform plate and the fronto sphenoidal suture, and
may extend from the crista galli to the tuberculum sellae (6).
Extension may be asymmetric and may compromise the ethmoid
sinuses, the nasal cavity, or even the orbit. (7). OGMs receive
their vascular supply primarily from the anterior and posterior
ethmoidal arteries, branches of the ophthalmic artery.
Risk factors for development of meningiomas include chromo-
some deletion, previous ionizing therapy, and head trauma (5).
The reported 2:1 female/male increases during reproductive years
FIGURE 3 | Progesterone receptor antibody staining, showing the
presence of PR in the specimen.
to 3.15:1 (8). Meningiomas may progress following contraceptive
implants, during the luteal phase of the menstrual cycle, or dur-
ing pregnancy (9, 10). Further studies have shown the presence of
estrogen, progesterone, and androgen receptors, with progesterone
receptors being present in 80% of meningiomas among women,
and only 40% among men (11). However, the potential correla-
tion of presence of hormone receptors and the natural history of
meningiomas has been inconsistent.
Incidence of meningiomas in pregnancy is not different than
in non-pregnant women. However, symptoms may flare up dur-
ing the first two trimesters of pregnancy, with subsequent tumoral
shrinkage post-partum and possible recurrence with subsequent
pregnancies (12, 13). Besides the proposed influence of sexual hor-
mones, this clinical flare-up has been attributed to water retention
and engorged blood vessels (14, 15).
In pregnant patients suspected of having an intracranial mas
lesion, MRI remains the preferred imaging modality because of
its greater resolution, increased sensitivity, and lack of ionizing
radiation. The use of gadolinium in pregnant patients controver-
sial as gadolinium can cross the placenta, but has not been shown
to cause birth defects (16, 17). CT carries the risk of ionizing
radiation to the fetus, but given its greater availability, lower cost,
and utility in assessing of calcifications, its use should be consid-
ered in selected circumstances and always with proper abdominal
shielding (18, 19).
Management of meningiomas during pregnancy requires a
multidisciplinary approach with close surveillance of mother and
fetus, with delivery at term and post-partum tumor resection
(20). Vaginal delivery is contraindicated in the presence of raised
ICP, because cerebrospinal fluid (CSF) pressure increases with
each uterine contractions during the second stage of labor (21).
However, tumor resection might be warranted before delivery in
patients with malignancy, active hydrocephalus requiring shunt-
ing, benign growth associated with signs of impending herniation,
or progressive neurologic deficits (14). Peripartum and periopera-
tively edema leading to ICP can be managed with tapering doses of
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dexamethasone. (22, 23). Mannitol should be used with caution,
given that it crosses the placenta and may affect the fetus. Its use
should only be limited to emergency situations (24). If seizures
occur, they should be treated appropriately, as the risk associated
with recurrent seizures is far greater than the risks of properly cho-
sen antiepileptic drugs (14). If tumor margins are not well defined,
or the nature of the meningioma is more aggressive with the poten-
tial for high risk of recurrence, adjuvant external beam radiation
in the early post operative period should be considered (21).
Olfactory groove meningiomas may grow rapidly during the
first two trimesters of pregnancy leading to devastating conse-
quences. Close monitoring with thorough neurologic examination
is recommended as the first step to assess any significant changes in
mass effect (25). The combination of unenhanced and enhanced
MRI is recommended for the detection of residual or recurrent
meningiomas after surgery.
Our patient presented with a symptomatic OGM that grew
during her pregnancy. Following a successful delivery, the menin-
gioma was removed.
REFERENCES
1. Kennedy F. Retrobulbar neuritis as an exact diagnostic sign of certain tumors
and abscesses in the frontal lobes.Am JMed Sci (1911) 142:355–68. doi:10.1097/
00000441-191109000-00005
2. Lotfipour S, Chiles K, Kahn JA, Bey T, Rudkin S. An unusual presentation of
subfrontal meningioma: a case report and literature review for Foster Kennedy
syndrome. Intern Emerg Med (2011) 6:267–9. doi:10.1007/s11739-010-0437-y
3. Ruben S, Elston J, Hayward R. Pituitary adenoma presenting as the Foster-
Kennedy syndrome. Br J Ophthalmol (1992) 76:117–9. doi:10.1136/bjo.76.2.117
4. Walia HS, Grumbine FL, Sawhney GK, Risner DS, Palejwala NV, Emanuel
ME, et al. An aggressive sphenoid wing meningioma causing Foster Kennedy
syndrome. Case Rep Ophthalmol Med (2012) 2012:102365. doi:10.1155/2012/
102365
5. Nakamura M, Struck M, Roser F, Vorkapic P, Samii M. Olfactory groove menin-
giomas: clinical outcome and recurrence rates after tumor removal through
the frontolateral and bifrontal approach. Neurosurgery (2008) 62:1224–32.
doi:10.1227/01.neu.0000333788.83349.1e
6. Bakay L, Cares HL. Olfactory meningiomas. report on a series of twenty-five
cases. Acta Neurochir Rep (1972) 26(1):1–12. doi:10.1007/BF01413528
7. Adappa ND, Lee JY, Chiu AG, Palmer JN. Olfactory groove meningioma. Oto-
laryngol Clin North Am (2011) 44(4):965–80. doi:10.1016/j.otc.2011.06.001
8. Claus EB, Black PM, Bondy ML, Calvocoressi L, Schildkraut JM, Wiemels
JL, et al. Exogenous hormone use and meningioma risk: what do we tell our
patients? Cancer (2007) 110(3):471–6. doi:10.1002/cncr.22783
9. Cowppli-Bony A, Bouvier G, Rué M, Loiseau H, Vital A, Lebailly P, et al. Brain
tumors and hormonal factors: review of the epidemiological literature. Cancer
Causes Control (2011) 22(5):697–714. doi:10.1007/s10552-011-9742-7
10. Bickerstaff ER, Small JM, Guest IA. The relapsing course of certain meningiomas
in relation to pregnancy and menstruation. J Neurol Neurosurg Psychiatry (1958)
21(2):89–91. doi:10.1136/jnnp.21.2.89
11. Vadivelu S, Sharer L, Schulder M. Regression of multiple intracranial menin-
giomas after cessation of long-term progesterone agonist therapy. J Neurosurg
(2010) 112:920–4. doi:10.3171/2009.8.JNS09201
12. Isla A, Alvarez F, Gonzalez A, Garcia-Grande A, Perez-Alvarez M, Garcia-
Blazquez M. Brain tumor and pregnancy. Obstet Gynecol (1997) 89:19–23.
doi:10.1016/S0029-7844(96)00381-X
13. Roelvink NC, Kamphorst W, van Alphen HA, Rao BR. Pregnancy-related pri-
mary brain and spinal tumors. Arch Neurol (1987) 44:209–15. doi:10.1001/
archneur.1987.00520140069020
14. Kanaan I, Jallu A, Kanaan H. Management strategy for meningioma in preg-
nancy: a clinical study. Skull Base (2003) 13(4):197–203. doi:10.1055/s-2004-
817695
15. Saitoh Y, Okum Y, Izumoto S, Go J. Rapid growth of a meningioma during
pregnancy: relationship with estrogen and progesterone receptors – case report.
Neurol Med Chir (Tokyo) (1989) 29:440–3. doi:10.2176/nmc.29.440
16. Edelman RR, Warach S. Magnetic resonance imaging. N Engl J Med (1993)
328:708–16. doi:10.1056/NEJM199303113281008
17. Sundgren PC, Leander P. Is administration of gadolinium-based contrast media
to pregnant women and small children justified? J Magn Reson Imaging (2011)
34:750–7. doi:10.1002/jmri.22413
18. Bonfield CM, Engh JA. Pregnancy and brain tumors. Neurol Clin (2012)
30:937–46. doi:10.1016/j.ncl.2012.04.003
19. Simon RH. Brain tumors in pregnancy. Semin Neurol (1988) 8:214–21. doi:10.
1055/s-2008-1041380
20. Lynch JC, Gouvea F, Emmerich JC, Kokinovrachos G, Pereira C, Welling L, et al.
Management strategy for brain tumour diagnosed during pregnancy. Br J Neu-
rosurg (2011) 25:225–30. doi:10.3109/02688697.2010.508846
21. Kasper EM, Hess PE, Silasi M, Lim KH, Gray J, Reddy H, et al. A pregnant
female with a large intracranial mass: reviewing the evidence to obtain manage-
ment guidelines for intracranial meningiomas during pregnancy. Surg Neurol
Int (2010) 1:95. doi:10.4103/2152-7806.74242
22. Chow MS, Mercier PA, Omahen DA, Wood SL, Johnson JA. Recurrent exophytic
meningioma in pregnancy.Obstet Gynecol (2013) 121:475–8. doi:10.1097/AOG.
0b013e31827e6251
23. Bradac GB, Ferszt R, Bender A, Schörner W. Peritumoral edema in meningiomas.
A radiological and histological study. Neuroradiology (1986) 28(4):304–12.
doi:10.1007/BF00333435
24. Balki M, Manninen PH. Craniotomy for suprasellar meningioma in a 28-week
pregnant woman without fetal heart rate monitoring. Can J Anaesth (2004)
51:573–6. doi:10.1007/BF03018400
25. Ojemann R. Meningiomas. Neurosurg Clin N Am (1990) 1:181–97.
Conflict of Interest Statement: The authors declare that the research was conducted
in the absence of any commercial or financial relationships that could be construed
as a potential conflict of interest.
Received: 13 September 2013; accepted: 26 October 2013; published online: 11
November 2013.
Citation: Rodríguez-Porcel F, Hughes I, Anderson D, Lee J and Biller J (2013) Foster
Kennedy syndrome due to meningioma growth during pregnancy. Front. Neurol. 4:183.
doi: 10.3389/fneur.2013.00183
This article was submitted to Neurology Education, a section of the journal Frontiers
in Neurology.
Copyright © 2013 Rodríguez-Porcel, Hughes, Anderson, Lee and Biller . This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) or licensor are credited and that the original publica-
tion in this journal is cited, in accordance with accepted academic practice. No use,
distribution or reproduction is permitted which does not comply with these terms.
www.frontiersin.org November 2013 | Volume 4 | Article 183 | 3
